Effects of BRAF and ERK inhibition on papillary and anaplastic thyroid cancer
收藏NIAID Data Ecosystem2026-05-01 收录
官方服务：
资源简介：
To investigate the effects of combined BRAF inhibition (dabrafenib) and ERK inhibition (ulixertinib) on papillary and anaplastic thyroid cancer transcriptional reprogramming Comparative gene expression profiling analysis of RNA-sequencing data for CUTC5 and CUTC60 cells treated with vehicle, dabrafenib, ulixertinib, or the combination
创建时间：
2023-06-15
